{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:15:21Z","timestamp":1790957721415,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005890","name":"Ministry of Health of the People's Republic of China","doi-asserted-by":"publisher","award":["LHGJ20210035"],"award-info":[{"award-number":["LHGJ20210035"]}],"id":[{"id":"10.13039\/501100005890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["222102310124"],"award-info":[{"award-number":["222102310124"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.intimp.2023.110102","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T02:27:06Z","timestamp":1682303226000},"page":"110102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Isobavachalcone ameliorates the progression of osteoarthritis by suppressing NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"119","author":[{"given":"Qi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.intimp.2023.110102_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072358","article-title":"The role of chondrocyte hypertrophy and senescence in osteoarthritis initiation and progression","volume":"21","author":"Rim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.110102_b0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.joca.2017.11.014","article-title":"Osteoarthritis year in review 2017: clinical","volume":"26","author":"Nelson","year":"2018","journal-title":"Osteoarthr. Cartil."},{"issue":"4","key":"10.1016\/j.intimp.2023.110102_b0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jbspin.2017.08.002","article-title":"Pain in osteoarthritis. Implications for optimal management","volume":"85","author":"Trouvin","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.intimp.2023.110102_b0020","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.omtn.2019.07.011","article-title":"Multi-pathway protective effects of microRNAs on human chondrocytes in an in vitro model of osteoarthritis","volume":"17","author":"Al-Modawi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"11","key":"10.1016\/j.intimp.2023.110102_b0025","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.autrev.2018.06.002","article-title":"Osteoarthritis and its management - epidemiology, nutritional aspects and environmental factors","volume":"17","author":"Bortoluzzi","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2023.110102_b0030","article-title":"Emerging natural-product-based treatments for the management of osteoarthritis","volume":"10","author":"Perez-Lozano","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2023.110102_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2010.01.035","article-title":"Abrogation of Akt signaling by Isobavachalcone contributes to its anti-proliferative effects towards human cancer cells","volume":"294","author":"Jing","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2023.110102_b0040","doi-asserted-by":"crossref","unstructured":"L.R. Assis, R.D.S. Theodoro, M.B.S. Costa, J.A.S. Nascentes, M.D.D. Rocha, M.A.S. Bessa, R.P. Menezes, G. Dilarri, G.B. Hypolito, V.R.D. Santos, C. Duque, H. Ferreira, C.H.G. Martins, L.O. Regasini, Antibacterial activity of isobavachalcone (IBC) Is associated with membrane disruption, Membranes (Basel) 12(3) (2022).","DOI":"10.3390\/membranes12030269"},{"issue":"1","key":"10.1016\/j.intimp.2023.110102_b0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.intimp.2012.11.005","article-title":"Isobavachalcone suppresses expression of inducible nitric oxide synthase induced by Toll-like receptor agonists","volume":"15","author":"Shin","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110102_b0050","doi-asserted-by":"crossref","first-page":"e0169560","DOI":"10.1371\/journal.pone.0169560","article-title":"Isobavachalcone attenuates MPTP-induced Parkinson's disease in mice by inhibition of microglial activation through NF-kappaB Pathway","volume":"12","author":"Jing","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2023.110102_b0055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/14786419.2016.1222387","article-title":"Flavonoids from the leaves and heartwoods of Artocarpus lowii King and their bioactivities","volume":"31","author":"Abdullah","year":"2017","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.intimp.2023.110102_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107370","article-title":"Isobavachalcone prevents osteoporosis by suppressing activation of ERK and NF-kappaB pathways and M1 polarization of macrophages","volume":"94","author":"Wang","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110102_b0065","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1002\/ptr.7246","article-title":"Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF-kappaB p65","volume":"35","author":"Zhou","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2023.110102_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115342","article-title":"Investigation of the mechanism of Isobavachalcone in treating rheumatoid arthritis through a combination strategy of network pharmacology and experimental verification","volume":"294","author":"Wang","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110102_b0075","first-page":"61","article-title":"Glucosamine promotes chondrocyte proliferation via the Wnt\/betacatenin signaling pathway","volume":"42","author":"Ma","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.intimp.2023.110102_b0080","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.joca.2013.06.016","article-title":"Pain, motor and gait assessment of murine osteoarthritis in a cruciate ligament transection model","volume":"21","author":"Ruan","year":"2013","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.intimp.2023.110102_b0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","article-title":"Osteoarthritis cartilage histopathology: grading and staging","volume":"14","author":"Pritzker","year":"2006","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2023.110102_b0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bmb\/lds038","article-title":"Epidemiology and burden of osteoarthritis","volume":"105","author":"Litwic","year":"2013","journal-title":"Br. Med. Bull."},{"issue":"1","key":"10.1016\/j.intimp.2023.110102_b0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keh344","article-title":"Osteoarthritis, angiogenesis and inflammation","volume":"44","author":"Bonnet","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2023.110102_b0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.907750","article-title":"Obesity, inflammation, and immune system in osteoarthritis","volume":"13","author":"Nedunchezhiyan","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110102_b0105","first-page":"4455","article-title":"Small extracellular vesicles in combination with sleep-related circRNA3503: a targeted therapeutic agent with injectable thermosensitive hydrogel to prevent osteoarthritis","volume":"6","author":"Tao","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.intimp.2023.110102_b0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bcp.2019.02.036","article-title":"Chondrocyte dedifferentiation and osteoarthritis (OA)","volume":"165","author":"Charlier","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110102_b0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.intimp.2017.02.009","article-title":"Fisetin inhibits IL-1beta-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice","volume":"45","author":"Zheng","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110102_b0120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10753-015-0278-y","article-title":"Echinocystic acid inhibits IL-1beta-induced COX-2 and iNOS expression in human osteoarthritis chondrocytes","volume":"39","author":"Ma","year":"2016","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/j.intimp.2023.110102_b0125","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review","volume":"20","author":"de Lange-Brokaar","year":"2012","journal-title":"Osteoarthr. Cartil."},{"issue":"11","key":"10.1016\/j.intimp.2023.110102_b0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110102_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040794","article-title":"Ginkgolide A ameliorates LPS-induced inflammatory responses in vitro and in vivo","volume":"18","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.110102_b0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.abb.2009.09.017","article-title":"Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes","volume":"491","author":"Campo","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.intimp.2023.110102_b0145","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1002\/jcp.29607","article-title":"Role of iNOS in osteoarthritis: pathological and therapeutic aspects","volume":"235","author":"Ahmad","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110102_b0150","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.joca.2008.04.022","article-title":"Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis","volume":"16","author":"Alvarez-Soria","year":"2008","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.intimp.2023.110102_b0155","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2020.04.011","article-title":"A novel target TAX1BP1 and P38\/Nrf2 pathway independently involved in the anti-neuroinflammatory effect of isobavachalcone","volume":"153","author":"Li","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110102_b0160","doi-asserted-by":"crossref","first-page":"9641","DOI":"10.1080\/21655979.2021.1974806","article-title":"Semaphorin 3A mitigates lipopolysaccharide-induced chondrocyte inflammation, apoptosis and extracellular matrix degradation by binding to Neuropilin-1","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"issue":"12","key":"10.1016\/j.intimp.2023.110102_b0165","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"sup1","key":"10.1016\/j.intimp.2023.110102_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","article-title":"Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs","volume":"31","author":"Jablonska-Trypuc","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.intimp.2023.110102_b0175","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/284873","article-title":"The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis","volume":"2013","author":"Maldonado","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2023.110102_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116786","article-title":"The role of matrix metalloproteinases in osteoarthritis pathogenesis: an updated review","volume":"234","author":"Mehana","year":"2019","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.intimp.2023.110102_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041742","article-title":"Overview of MMP-13 as a promising target for the treatment of osteoarthritis","volume":"22","author":"Hu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2023.110102_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070734","article-title":"NF-kappaB signaling pathways in osteoarthritic cartilage destruction","volume":"8","author":"Choi","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.intimp.2023.110102_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083807","article-title":"Obeticholic acid derivative, T-2054 suppresses osteoarthritis via inhibiting NF-kappaB-signaling pathway","volume":"22","author":"Guo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2023.110102_b0200","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1002\/jcp.30392","article-title":"Small molecule natural compound targets the NF-kappaB signaling and ameliorates the development of osteoarthritis","volume":"236","author":"Xu","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110102_b0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","article-title":"NF-kappaB: a key role in inflammatory diseases","volume":"107","author":"Tak","year":"2001","journal-title":"J .Clin. Invest."},{"issue":"11","key":"10.1016\/j.intimp.2023.110102_b0210","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.biocel.2013.08.018","article-title":"The NF-kappaB signalling pathway in osteoarthritis","volume":"45","author":"Rigoglou","year":"2013","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110102_b0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300423X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692300423X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:18:26Z","timestamp":1785770306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692300423X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"alternative-id":["S156757692300423X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110102","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isobavachalcone ameliorates the progression of osteoarthritis by suppressing NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110102"}}